qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinale stromale tumorer - antineoplastiske midler - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosuppressiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
prucalopride "holsten" 1 mg filmovertrukne tabletter
holsten pharma gmbh - prucalopridsuccinat - filmovertrukne tabletter - 1 mg
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastiske midler - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.
voriconazol "accordpharma" 50 mg filmovertrukne tabletter
accord healthcare b.v. - voriconazol - filmovertrukne tabletter - 50 mg
voriconazol "accordpharma" 200 mg pulver til infusionsvæske, opløsning
accord healthcare b.v. - voriconazol - pulver til infusionsvæske, opløsning - 200 mg
tigecycline "panpharma" 50 mg pulver til infusionsvæske, opløsning
panmedica - tigecyclin - pulver til infusionsvæske, opløsning - 50 mg
voriconazol "accordpharma" 200 mg filmovertrukne tabletter
accord healthcare b.v. - voriconazol - filmovertrukne tabletter - 200 mg
betmiga
astellas pharma europe b.v. - mirabegron - urinblære, overaktiv - urologicals - symptomatisk behandling af uopsættelighed. Øget micturition frekvens og / eller hastende inkontinens, som kan opstå hos voksne patienter med overaktiv-blære syndrom.
bretaris genuair
covis pharma europe b.v. - aclidinium bromide - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - bretaris genuair er indiceret som vedligeholdelsesbronkodilatorbehandling for at lindre symptomer hos voksne patienter med kronisk obstruktiv lungesygdom (copd).